Consider Affinity Bio Partners. The privately held clinical research organization located outside Philadelphia, PA, is expanding its conventional business in the US to run a few tests overseas and is also starting to pull in more foreign clients. The number of medical cannabis trials will double this year, according to CEO Christina DiArcangelo Puller. “Things are on the upswing,” she said.
Understanding The Evolving Medical Cannabis Market
Exploring The Market Potential And Challenges Presented By A Boom In Medical Cannabis Companies
In case you have not noticed, a new gold rush appears to be under way. Buoyed by surging interest in medical cannabis, big and small companies from around the world are racing to take advantage of the potential for the marijuana plant to cure numerous diseases and take its place in the pantheon of pharmaceutical products.
